HOGG1 C1245G gene polymorphism associated with prostate cancer: A meta-analysis

International Journal of Biological Markers

Volumn 30, Issue 2, 2015, Pages e161-e168

  Chen, Yang ^a,b   Li, Jie ^a,b   Li, Tianyu ^a,b   Mo, Zengnan ^a,b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

HOGG1; Human oxoguanine glycosylase 1; Polymorphism; Prostate cancer

Indexed keywords

DNA GLYCOSYLTRANSFERASE; HUMAN OXOGUANINE GLYCOSYLASE 1; UNCLASSIFIED DRUG; OXOGUANINE GLYCOSYLASE 1, HUMAN;

AFRICA; AFRICAN; ASIAN; AUSTRALIA; CANCER RECURRENCE; CAUCASIAN; DNA POLYMORPHISM; DOMINANT GENE; EUROPE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN OXOGUANINE GLYCOSYLASE 1 GENE; META ANALYSIS; PROSTATE CANCER; RECESSIVE GENE; REVIEW; UNITED STATES; GENETIC POLYMORPHISM; GENETICS; MALE; PROSTATE TUMOR;

DNA GLYCOSYLASES; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 84934768546     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000144     Document Type: Review

References (39)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. PubMed: 18287387.
2. McCracken M, Olsen M, Chen MS Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57(4):190-205. PubMed: 17626117.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43-66. PubMed: 17237035.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249. PubMed: 19474385.
5. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220-241. PubMed: 22700443.
6. Bostwick DG, Burke HB, Djakiew D, et al. Human prostate cancer risk factors. Cancer. 2004;101(10)(Suppl):2371-2490. PubMed: 15495199.
7. Chen Y, Li T, Yu X, et al. The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies. Gene. 2014;534(2):286-297. PubMed: 24177231.
8. Zhou C, Xie LP, Lin YW, Yang K, Mao QQ, Cheng Y. Susceptibility of XPD and hOGG1 genetic variants to prostate cancer. Biomed Rep. 2013;1(4):679-683. PubMed: 24649009.
9. Rosenquist TA, Zharkov DO, Grollman AP. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci USA. 1997;94(14):7429-7434. PubMed: 9207108.
10. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys. 2000;377(1):1-8. PubMed: 10775435.
11. Kamiya H, Miura K, Ishikawa H, Inoue H, Nishimura S, Ohtsuka E. c-Ha-ras containing 8-hydroxyguanine at codon 12 induces point mutations at the modified and adjacent positions. Cancer Res. 1992;52(12):3483-3485. PubMed: 1596906.
12. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys. 2000;377(1):1-8. PubMed: 10775435.
13. Kohno T, Shinmura K, Tosaka M, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16(25):3219-3225. PubMed: 9681819.
14. Xie H, Xia K, Rong H, Chen X. Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. Breast. 2013;22(5):707-712. PubMed: 23369609.
15. Cheng Z, Wang W, Song YN, Kang Y, Xia J. hOGG1, p53 genes, and smoking interactions are associated with the development of lung cancer. Asian Pac J Cancer Prev. 2012;13(5):1803-1808. PubMed: 22901126.
16. Wang YH, Yeh SD, Shen KH, et al. Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan. Anticancer Res. 2011;31(11):3939-3944. PubMed: 22110223.
17. Xu J, Zheng SL, Turner A, et al. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res. 2002;62(8):2253-2257. PubMed: 11956079.
18. Chen L, Elahi A, Pow-Sang J, Lazarus P, Park J. Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol. 2003;170(6 Pt 1):2471-2474. PubMed: 14634453.
19. Lavender NA, Komolafe OO, Benford M, et al. No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate. 2010;70(2):113-119. PubMed: 19760636.
20. Mandal RK, Gangwar R, Kapoor R, Mittal RD. Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population. Indian J Med Res. 2012;135(1):64-71. PubMed: 22382185.
21. Mittal RD, Mandal RK, Gangwar R. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population. Mech Ageing Dev. 2012;133(4):127-132. PubMed: 22019847.
22. Yun SJ, Ha YS, Chae Y, Kim JS, Kim IY, Kim WJ. The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Ann Oncol. 2012;23(2):401-405. PubMed: 21515665.
23. Zhang J, Dhakal IB, Greene G, Lang NP, Kadlubar FF. Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology. 2010;75(4):779-785. PubMed: 19914697.
24. Dhillon VS, Yeoh E, Fenech M. DNA repair gene polymorphisms and prostate cancer risk in South Australia: results of a pilot study. Urol Oncol. 2011;29(6):641-646. PubMed: 19914098.
25. Nock NL, Cicek MS, Li L, et al. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis. 2006;27(9):1842-1848. PubMed: 16569655.
26. Nam RK, Zhang WW, Jewett MA, et al. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res. 2005;11(23):8391-8397. PubMed: 16322300.
27. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820-826. PubMed: 9382404.
28. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta- analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-634. PubMed: 9310563.
29. Dluzniewski PJ, Wang MH, Zheng SL, et al. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1774-1782. PubMed: 22859398.
30. Grundmark B, Zethelius B, Garmo H, Holmberg L. Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk: a 34 year ULSAM follow-up. BMC Cancer. 2011;11(1):431. PubMed: 21982398.
31. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control. 2010;21(2):289-300. PubMed: 19902366.
32. Zhang H, Xu Y, Zhang Z, Li L. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls. BMC Cancer. 2011;11(1):391. PubMed: 21914193.
33. 326Cys polymorphism to the development of prostate cancer in smokers: meta-analysis of 2779 cases and 3484 controls. PLoS ONE. 2012;7(1):e30309. PubMed: 22279581.
34. Zhu S, Zhang H, Tang Y, Wang J. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis. Urol Int. 2012;89(2):233-240. PubMed: 22890093.
35. Wang W, Wang M, Chen Y, et al. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies. Mutagenesis. 2012;27(3):329-336. PubMed: 22121210.
36. Walsh PC. Associations between hOGG1 sequence variants and prostate cancer susceptibility. J Urol. 2002;168(4 Pt 1):1636. PubMed: 12356046.
37. Ma L, Chu H, Wang M, et al. hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study. Cancer Sci. 2012;103(7):1215-1220. PubMed: 22463382.
38. Li Q, Huang L, Rong L, et al. hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci. 2011;102(6):1123-1127. PubMed: 21401806.
39. Okasaka T, Matsuo K, Suzuki T, et al. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J Hum Genet. 2009;54(12):739-745. PubMed: 19881468.